NO20013146L - Middel for behandling av synscellefunksjonsforstyrrelse - Google Patents
Middel for behandling av synscellefunksjonsforstyrrelseInfo
- Publication number
- NO20013146L NO20013146L NO20013146A NO20013146A NO20013146L NO 20013146 L NO20013146 L NO 20013146L NO 20013146 A NO20013146 A NO 20013146A NO 20013146 A NO20013146 A NO 20013146A NO 20013146 L NO20013146 L NO 20013146L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- cell dysfunction
- visual cell
- visual
- dysfunction
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11393998P | 1998-12-24 | 1998-12-24 | |
| PCT/JP1999/007161 WO2000038703A1 (en) | 1998-12-24 | 1999-12-20 | Agent for treating visual cell function disorder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20013146D0 NO20013146D0 (no) | 2001-06-22 |
| NO20013146L true NO20013146L (no) | 2001-08-20 |
Family
ID=22352417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20013146A NO20013146L (no) | 1998-12-24 | 2001-06-22 | Middel for behandling av synscellefunksjonsforstyrrelse |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1140134A1 (zh) |
| JP (1) | JP2002542150A (zh) |
| KR (1) | KR20010099928A (zh) |
| CN (1) | CN1224420C (zh) |
| AR (1) | AR022017A1 (zh) |
| AU (1) | AU781049B2 (zh) |
| BR (1) | BR9917113A (zh) |
| CA (1) | CA2356382A1 (zh) |
| MX (1) | MXPA01006449A (zh) |
| NO (1) | NO20013146L (zh) |
| NZ (1) | NZ513111A (zh) |
| TW (1) | TW546145B (zh) |
| WO (1) | WO2000038703A1 (zh) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070032853A1 (en) | 2002-03-27 | 2007-02-08 | Hossainy Syed F | 40-O-(2-hydroxy)ethyl-rapamycin coated stent |
| AU2003209297A1 (en) | 2002-01-18 | 2003-09-02 | Massachusetts Eye And Ear Infirmary | Methods and compositions for preserving the viability of photoreceptor cells |
| WO2004027027A2 (en) | 2002-09-18 | 2004-04-01 | Trustees Of The University Of Pennsylvania | Method of inhibiting choroidal neovascularization |
| US20050118344A1 (en) | 2003-12-01 | 2005-06-02 | Pacetti Stephen D. | Temperature controlled crimping |
| PL1848431T3 (pl) | 2005-02-09 | 2016-08-31 | Santen Pharmaceutical Co Ltd | Ciekłe formulacje do leczenia chorób lub stanów |
| WO2007019427A2 (en) * | 2005-08-08 | 2007-02-15 | Massachusetts Eye & Ear Infirmary | Methods and compositions for preserving the viability of photoreceptor cells |
| CN101605529B (zh) | 2006-02-09 | 2013-03-13 | 参天制药株式会社 | 稳定制剂及它们的制备和使用方法 |
| BRPI0709016A2 (pt) | 2006-03-23 | 2011-06-21 | Macusight Inc | formulações e métodos para doenças ou condições relacionadas com a permeabilidade vascular |
| EP3868407A4 (en) * | 2018-10-15 | 2022-02-23 | Osaka University | MEDICINE FOR IMPROVING OR PREVENTING RETINA AND/OR PHOTORECEPTION RELATED SYMPTOMS AND METHOD FOR SCREENING SUBSTANCE FOR IMPROVING OR PREVENTING RETINA AND/OR PHOTORECEPTION RELATED SYMPTOMS |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69124380T2 (de) * | 1990-08-23 | 1997-08-14 | Univ New York | Verfahren und zusammensetzungen für die behandlung durch t-zellen vermittelter krankheiten |
| ZA924953B (en) * | 1991-07-25 | 1993-04-28 | Univ Louisville Res Found | Method of treating ocular inflammation |
| US5922773A (en) * | 1992-12-04 | 1999-07-13 | The Children's Medical Center Corp. | Glaucoma treatment |
| US5597809A (en) * | 1994-06-23 | 1997-01-28 | Massachusetts Eye & Ear Infirmary | Treatment of optic neuritis |
| WO1999000129A1 (en) * | 1997-06-30 | 1999-01-07 | Dreyer Evan B | Calcium blockers to treat proliferative vitreoretinopathy |
| CZ287497B6 (cs) * | 1997-12-30 | 2000-12-13 | Galena, A. S. | Topické oční přípravky s imunosupresivními látkami |
| US6376517B1 (en) * | 1998-08-14 | 2002-04-23 | Gpi Nil Holdings, Inc. | Pipecolic acid derivatives for vision and memory disorders |
-
1999
- 1999-12-20 JP JP2000590655A patent/JP2002542150A/ja active Pending
- 1999-12-20 AU AU16906/00A patent/AU781049B2/en not_active Ceased
- 1999-12-20 MX MXPA01006449A patent/MXPA01006449A/es unknown
- 1999-12-20 NZ NZ513111A patent/NZ513111A/en unknown
- 1999-12-20 CN CNB998162760A patent/CN1224420C/zh not_active Expired - Fee Related
- 1999-12-20 WO PCT/JP1999/007161 patent/WO2000038703A1/en not_active Application Discontinuation
- 1999-12-20 EP EP99959930A patent/EP1140134A1/en not_active Withdrawn
- 1999-12-20 BR BR9917113-9A patent/BR9917113A/pt not_active IP Right Cessation
- 1999-12-20 CA CA002356382A patent/CA2356382A1/en not_active Abandoned
- 1999-12-20 KR KR1020017008060A patent/KR20010099928A/ko not_active Application Discontinuation
- 1999-12-22 TW TW088122634A patent/TW546145B/zh not_active IP Right Cessation
- 1999-12-23 AR ARP990106748A patent/AR022017A1/es not_active Application Discontinuation
-
2001
- 2001-06-22 NO NO20013146A patent/NO20013146L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1352565A (zh) | 2002-06-05 |
| EP1140134A1 (en) | 2001-10-10 |
| AR022017A1 (es) | 2002-09-04 |
| WO2000038703A1 (en) | 2000-07-06 |
| AU781049B2 (en) | 2005-05-05 |
| JP2002542150A (ja) | 2002-12-10 |
| AU1690600A (en) | 2000-07-31 |
| CA2356382A1 (en) | 2000-07-06 |
| TW546145B (en) | 2003-08-11 |
| KR20010099928A (ko) | 2001-11-09 |
| NZ513111A (en) | 2003-10-31 |
| MXPA01006449A (es) | 2002-04-24 |
| CN1224420C (zh) | 2005-10-26 |
| BR9917113A (pt) | 2001-10-23 |
| NO20013146D0 (no) | 2001-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS2494B (is) | Notkun á morfólínóli til meðhöndlunar á kynferðislegri vanvirkni | |
| DE60020327D1 (de) | Wasserbehandlungsvorrichtung | |
| NO20012160D0 (no) | Anordning for behandling av makulös degenerering | |
| EE200200710A (et) | Asendatud bitsüklilised derivaadid ebanormaalse rakukasvu raviks | |
| DE69828821D1 (de) | Wasserbehandlungsverfahren | |
| NO952749D0 (no) | Middel for vannbehandling | |
| EA199900336A3 (ru) | Аппарат для очистки воды с индикатором степени истощения средства для очистки | |
| DK0965566T3 (da) | Fremgangsmåde til behandling af organisk spildevand | |
| NO20010456L (no) | Triazolopyridiner for behandling av trombose lidelser | |
| NO20013146D0 (no) | Middel for behandling av synscellefunksjonsforstyrrelser | |
| NO20012106L (no) | Middel for behandling av forstyrrelser i benmetabolismen | |
| NO20013596D0 (no) | Slambehandling | |
| AU4774599A (en) | Process for the treatment of waste water | |
| DK1054868T3 (da) | Substituerede pyridinoarylpiperaziner egnede til behandling af prostatahyperplasi | |
| AU3814599A (en) | Use of erythropoietin for the treatment of haemochromatoses | |
| NO20011892L (no) | 3-tetrahydropyridin-4-yl-indoler for behandling av psykotiske forstyrrelser | |
| NO20003481D0 (no) | FremgangsmÕte for behandling av COPD | |
| FI982378A0 (fi) | Järjestely kohteen tutkimiseen | |
| NO20012612D0 (no) | Isonipecotamider for behandling av integren-formidlede lidelser | |
| AU3843600A (en) | Bath equipped with water vibrator and therapeutic method using the same | |
| NO20012616L (no) | Middel til behandling av erektil malfunksjon | |
| GB2332849B (en) | Apparatus for the treatment of soil | |
| FI981803A0 (fi) | Menetelmä saostumien muodostumisen estämiseksi | |
| DE50015962D1 (de) | System zur Aufbereitung von Trinkwasser | |
| NO996166L (no) | FremgangsmÕte for behandling av avluter |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |